MedPath

Zortomib

Brand Name: Zortomib

Generic Name: Bortezomib

Expiring Soon
Registration Number

DRP-9481

Dosage Form

Lyophilized Powder For Injection (IV/SC)

Issuance Date

February 2, 2021

Expiry Date

February 2, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.5 mg
Packaging10 mL clear, moulded, Type I glass vial with bromobutyl rubber stopper, aluminum flip-off seal and green polypropylene cap (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

BortezomibActive
Monograph: Bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform